Trademark: CONTRA-MAB
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for CONTRA-MAB
We do not have any records of a proof of use for CONTRA-MAB at this moment.
Possible trademark infringements of CONTRA-MAB
Basic Information about CONTRA-MAB
- Serial Number
- 88081271
- Filing Date
- 16 Aug 2018
- Registration Number
- 6029997
- Registration Date
- 07 Apr 2020
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of CONTRA-MAB on the blockchain with WikiTrademarks.io.
- First use of CONTRA-MAB anywhere
- CONTRA-MAB was first used on 10 Sep 2019 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns CONTRA-MAB?
1. INHIBRX BIOSCIENCES, INC. LA JOLLA CA
2. INHIBRX, INC. La Jolla CA
3. INHIBRX, INC. La Jolla CA
4. INHIBRX, INC. La Jolla CA
Correspondent
- ANDREW D. SKALE MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C
- 3580 CARMEL MOUNTAIN ROAD
- SUITE 300
- SAN DIEGO, CA 92130
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io